Related references
Note: Only part of the references are listed.Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease
Akira Mima
ADVANCES IN THERAPY (2021)
Women and babies are dying from inertia: a collaborative framework for obstetrical drug development is urgently needed
Edith Roset Bahmanyar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
New insight into podocyte slit diaphragm, a therapeutic target of proteinuria
Hiroshi Kawachi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Analysis of SIRT1 Expression in Plasma and in an In Vitro Model of Preeclampsia
Sarah Viana-Mattioli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
Issei Tomita et al.
CELL METABOLISM (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Maternal serum AMP-activated protein kinase levels in mild and severe preeclampsia
Nadiye Koroglu et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2019)
Ambulatory Blood Pressure Reduction With SGLT-2 Inhibitors: Dose-Response Meta-analysis and Comparative Evaluation With Low-Dose Hydrochlorothiazide
Panagiotis I. Georgianos et al.
DIABETES CARE (2019)
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Elizabeth A. Phipps et al.
NATURE REVIEWS NEPHROLOGY (2019)
A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia
Bianca Covella et al.
KIDNEY INTERNATIONAL (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pre-eclampsia: pathophysiology and clinical implications
Graham J. Burton et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
Ali S. Khashan et al.
PLOS MEDICINE (2019)
Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia
Eugenie R. Lumbers et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering
Brendon L. Neuen et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Cross-Talk between Oxidative Stress and Inflammation in Preeclampsia
Marilene Brandao Tenorio et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms
Soravis Osataphan et al.
JCI INSIGHT (2019)
Current model systems for the study of preeclampsia
M. L. Martinez-Fierro et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
Akira Mima
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Hiddo J. L. Heerspink et al.
KIDNEY INTERNATIONAL (2018)
Biomarkers of glomerular dysfunction in pre-eclampsia - A systematic review
Robert N. Kerley et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)
Nephrin Signaling in the Podocyte: An Updated view of Signal Regulation at the Slit Diaphragm and Beyond
Claire E. Martin et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeciampsia
Nathan Campbell et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity
Ningning Wan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
Paola Cassis et al.
JCI INSIGHT (2018)
Loss of slit protein nephrin is associated with reduced antioxidant superoxide dismutase expression in podocytes shed from women with preeclampsia
Yuping Wang et al.
PHYSIOLOGICAL REPORTS (2018)
Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6-Calcium / Calcineurin Pathway in Pre-Eclampsia
Ying Yu et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
AMPK activators: mechanisms of action and physiological activities
Joungmok Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Towards an understanding of kidney diseases associated with WT1 mutations
Lihua Dong et al.
KIDNEY INTERNATIONAL (2015)
Increased urinary levels of podocyte glycoproteins, matrix metallopeptidases, inflammatory cytokines, and kidney injury biomarkers in women with preeclampsia
Yuping Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
William L. Baker et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes A Systematic Review and Meta-analysis
Despoina Vasilakou et al.
ANNALS OF INTERNAL MEDICINE (2013)
Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process
Antero Salminen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cell Biology and Pathology of Podocytes
Anna Greka et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)
Sodium-Glucose Cotransporter Inhibition Prevents Oxidative Stress in the Kidney of Diabetic Rats
Horacio Osorio et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Angiotensin II Type 1 Autoantibody Induced Hypertension During Pregnancy Is Associated With Renal Endothelial Dysfunction
Marc R. Parrish et al.
GENDER MEDICINE (2011)
FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression
Shiqin Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
Vincent W. S. Lee et al.
NEPHROLOGY (2011)
A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
Jan Basile
POSTGRADUATE MEDICINE (2011)
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice
Cissy C. Zhou et al.
NATURE MEDICINE (2008)
Preeclampsia and the risk of end-stage renal disease
Bjorn Egil Vikse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes
Etsuko Yanagida-Asanuma et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Dynamic FoxO transcription factors
Haojie Huang et al.
JOURNAL OF CELL SCIENCE (2007)
Urinary podocyte excretion as a marker for preeclampsia
Vesna D. Garovic et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Activating auto-antibodies against the AT1 receptor in preeclampsia
R Dechend et al.
AUTOIMMUNITY REVIEWS (2005)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Share Paper
